Doctors advised to use Remdesivir on COVID-19 patients strictly under laid-down protocol

To prevent black-marketing and overcharging of the drug, India's drug regulator Drugs Controller General of India (DCGI) has asked manufacturers to set up a helpline where the patients or their family members can contact in case the drug is not available in the market and also put on their websites details of distributors and supply chain.
Source: The Economic Times - Category: Consumer Health News Source Type: news